Case Study - Partner Identification Consulting Services

Objective :

Partners Identification for client’s early-stage oncology based clinical product for late-stage clinical development and commercialization.

Problem Statement:

A medium pharmaceutical client based in the US, with innovative formulations to treat Head and Neck Cancer, involved DelveInsight to identify a co-development partner, for the US and European region. The client was interested to involve a pharmaceutical company with experience around oncology, capabilities to develop the product through its clinical development cycle and also support commercial manufacturing for launching the product in the two regions.

Our Methodology:

Oncology Market Assessment
Assessment of Companies with Development and Commercialization Capabilities
Deal/Investment Assessment
Interest in Client’s candidate
5-10 Potential Partners

Results:

Extensive Listing of Companies with requisite capabilities
Matrix Analysis of the top 25 companies researched.
The client could assess the Top 5-10 companies that fit their strategic needs and were interested in the partnership.
Final Engagement through DelveInsight to take the discussions forward.

Related case Studies

Portfolio Management R&D Analysis Asset Prioritization Launch Landscape Analysis Pipeline Assessment Competitive Intelligence Mergers and Acquisitions

Sample Visuals

Get Visuals

Related Insights

Portfolio Management

A small-Pharma client based in Israel involved DelveInsight to manage their portfolio of candidates indicated for various infectious diseases. [...]

View Case

R&D Analysis

A mid-Pharma client based in India involved DelveInsight to assist in gathering and analyzing congress abstracts and literature review from various congresses for Parkinson’s disease. [...]

View Case

Asset Prioritization

A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]

View Case